how does glp-1 work GLP-1s: What They Are and

Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

Nitric oxide has fundamental vasodilator properties, reducing systemic vascular resistance and improving artery compliance, all of which would alleviate the haemodynamic burden in HF

There are additional concerns

Therefore, a DPP-IV resistant glucagon was conjugated with T3 (Gcg/T3) via a gamma-glutamic acid linker to target GcgR-expressing hepatic and white adipose tissue [54]

Clinical Presentation The clinical presentation of PD is typically categorized into two main groups: motor symptoms and nonmotor symptoms

Some patients experience plateaus earlier, which may respond to dose adjustments or medication switches